Lataa...
Crizotinib in the treatment of non-small-cell lung carcinoma
Recent studies have demonstrated the benefit of EGFR tyrosine kinase inhibitors in the treatment of advanced non-small-cell lung cancer (NSCLC). The role of activation of the anaplastic lymphoma kinase (ALK) pathway and the presence of the fusion gene EML4-ALK are new molecular targets in studies in...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Termedia Publishing House
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3687470/ https://ncbi.nlm.nih.gov/pubmed/23788933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2012.32477 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|